Benign Prostatic Hyperplasia: Trouble With Dribbles Level II
Cat allergy (recent onset with adoption of new cat)
QUESTIONS
Collect Information
1.a. What subjective and objective information is consistent with the presence of BPH?
1.b. What additional information is needed to fully assess this patient’s BPH (Figure 981)?
FIGURE 981.
The American Urologic Association (AUA) symptom index for benign prostatic hyperplasia (BPH). (Reproduced from article in the public domain: Barry
MJ, Fowler FJ Jr, O’Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement
Committee of the American Urological Association. J Urol 1992;148(5):1549–1557.)
Assess the Information
2.a. Assess the severity of BPH based on the subjective and objective information available.
2.b. Create a list of the patient’s drug therapy problems and prioritize them. Include assessment of medication appropriateness, effectiveness, safety,
and patient adherence.
2.c. Describe the natural history and epidemiologic characteristics of BPH.
2.d. What other medical conditions should be ruled out before treating this patient for BPH?
Develop a Care Plan
3.a. What are the goals of pharmacotherapy in this case?
3.b. What nondrug therapies might be useful for this patient?
3.c. What feasible pharmacotherapeutic alternatives are available for treating BPH?
3.d. Create an individualized, patientcentered, teambased care plan to optimize medication therapy for this patient. Include specific drugs, dosage
forms, doses, schedules, and durations of therapy.
Implement the Care Plan
4.a. What information should be provided to the patient to enhance compliance, ensure successful therapy, and minimize adverse effects?
4.b. Describe how care should be coordinated with other healthcare providers.
5.a. What clinical and laboratory parameters should be used to evaluate the therapy for achievement of the desired therapeutic outcome and to detect
or prevent adverse effects?
5.b. Develop a plan for followup that includes appropriate time frames to assess progress toward achievement of the goals of therapy.
